Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03434080 · ClinicalTrials.gov registry record

Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral Palsy

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Terminated
Registry status
26
Enrollment target

NCT03434080: Clinical Trial study, sponsored by National Institutes of Health Clinical Center (CC).

NCT03434080 is a clinical trial that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03434080 was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).

TERMINATED
Registry status
26 participants
Enrollment target

Study Summary

Background: New ways to study the brain as people move include near-infrared spectroscopy (NIRS) and electroencephalography (EEG). NIRS uses laser light shone through the scalp to look at blood flow in the brain which increases with movement. EEG records electrical activity in the brain. Little is known about brain activity while children learn new motor skills. Researchers want to learn more about how small children with and without cerebral palsy use their brain to control their body. This may help them find new ways to help children move better. Objectives: To learn more about how infants and young children with and without cerebral palsy use their brain to move their arms and legs. Eligibility: Children ages 3 months - 5 years with and without cerebral palsy Design: Participants will be screened with: * Physical exam * Questions for the parents about the child s health Participants will have at least 1 study session. Some may have up to 34 (all optional). In the sessions, participants will do motor tasks along with some or all of the following: * Light sensors placed on the scalp, held there with a cap or Velcro straps. * Small metal disks placed on the scalp with a cap or straps, with gel between them. * Motion capture recording. Balls attached to the arms and legs by stickers, straps, or a garment are tracked by infrared and video cameras. Motor tasks include reaching, clapping, kicking, and standing. Participants may be placed in a toy or device that uses a motor to move their limbs. Participants head size, hair, and skin will be assessed. Parents will answer questions about their child s typical movements. ...

Primary Outcome

Data from each of the techniques will be compared across subjects group.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2018-05-16
Est. Completion 2025-08-21

Why NCT03434080 stopped before completion

NCT03434080 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03434080 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03434080 about?

NCT03434080 is a clinical study titled "Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral Palsy". Background: New ways to study the brain as people move include near-infrared spectroscopy (NIRS) and electroencephalography (EEG). NIRS uses laser light shone through the scalp to look at blood flow in the brain which increases with movement. EEG records electrical activity in the brain. Little is ...

What is the current status of trial NCT03434080?

This trial is currently terminated. The enrollment target is 26 participants. The study started on 2018-05-16. Estimated completion is 2025-08-21.

Who is sponsoring clinical trial NCT03434080?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03434080, the US trial registry maintained by the National Library of Medicine. NCT03434080 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.